Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene
- PMID: 17893251
- DOI: 10.1530/EJE-07-0533
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene
Abstract
Background: Germline aryl hydrocarbon receptor-interacting protein (AIP) mutations occur in 15% of familial isolated pituitary adenoma (FIPA) cases. To date, studies have focused on the identification of such mutations in large international cohorts. Detailed genetic and clinical studies within AIP mutation-positive families have been limited.
Aim: To undertake a comprehensive study of a large Brazilian FIPA kindred with an E174 frameshift (E174fs) AIP mutation to assess clinical, hormonal, and radiological features in mutation carriers.
Methods: The kindred included 122 subjects across six generations; all underwent clinical examination. Genetic studies were performed to identify E174fs mutation carriers. E174fs-positive subjects underwent magnetic resonance imaging (MRI) and hormonal assessments.
Results: Of the ten germline AIP mutation carriers, three had pituitary tumors, while seven were asymptomatic carriers. Three patients with pituitary tumors showed variability in terms of tumor phenotype (two with acromegaly, one with prolactinoma, or mixed prolactin/GH-secreting tumor) and age at diagnosis; both patients with acromegaly had poor responses to octreotide. Tumor AIP immunohistochemistry from the operated patient showed decreased expression when compared with normal tissue. Two adult subjects with normal MRI had elevated IGF-I in the absence of other causes. A 2-year-old child with the E174fs mutation and a normal MRI had premature thelarche, ovarian development, and advanced bone age in the absence of other underlying causes.
Conclusions: The penetrance of pituitary tumors in AIP mutation-positive adult subjects was 33.3%, while clinical/hormonal features were variable. The features noted in AIP-mutation carriers in this kindred suggest that clinical characteristics of such carriers may extend beyond pituitary tumors.
Similar articles
-
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.J Clin Endocrinol Metab. 2007 May;92(5):1891-6. doi: 10.1210/jc.2006-2513. Epub 2007 Jan 23. J Clin Endocrinol Metab. 2007. PMID: 17244780
-
Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.Eur J Endocrinol. 2009 Nov;161(5):799-804. doi: 10.1530/EJE-09-0406. Epub 2009 Aug 14. Eur J Endocrinol. 2009. PMID: 19684062
-
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54. doi: 10.1210/jc.2015-1869. J Clin Endocrinol Metab. 2015. PMID: 26186299 Free PMC article.
-
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31. Endocr Rev. 2013. PMID: 23371967 Free PMC article. Review.
-
[AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].Endocrinol Nutr. 2009 Aug-Sep;56(7):369-77. doi: 10.1016/S1575-0922(09)72456-8. Endocrinol Nutr. 2009. PMID: 19883897 Review. Spanish.
Cited by
-
Clinical and genetic aspects of familial isolated pituitary adenomas.Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):37-41. doi: 10.6061/clinics/2012(sup01)08. Clinics (Sao Paulo). 2012. PMID: 22584704 Free PMC article. Review.
-
Familial isolated pituitary adenomas: from genetics to therapy.Clin Transl Sci. 2011 Feb;4(1):55-62. doi: 10.1111/j.1752-8062.2010.00254.x. Clin Transl Sci. 2011. PMID: 21348957 Free PMC article. Review.
-
Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family.Int J Endocrinol. 2018 Apr 4;2018:8581626. doi: 10.1155/2018/8581626. eCollection 2018. Int J Endocrinol. 2018. PMID: 29849625 Free PMC article.
-
Familial pituitary tumor syndromes.Nat Rev Endocrinol. 2009 Aug;5(8):453-61. doi: 10.1038/nrendo.2009.126. Epub 2009 Jun 30. Nat Rev Endocrinol. 2009. PMID: 19564887 Review.
-
Aryl hydrocarbon receptor interacting protein mutations seem not to associate with familial non-medullary thyroid cancer.J Endocrinol Invest. 2009 May;32(5):426-9. doi: 10.1007/BF03346480. J Endocrinol Invest. 2009. PMID: 19794292
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous